This may be related to low tPSA, early-stage disease (being castration-sensitive), high PSMA expression even in poorly differentiated PCa, tumor heterogeneity, sub-centimetric lesions and early bone marrow involvement. This evidence concerns the gene FOLH1 and neoplasm.